206 related articles for article (PubMed ID: 33882252)
1. Differentiation between endometriosis-associated ovarian cancers and non- endometriosis-associated ovarian cancers based on magnetic resonance imaging.
Zhang X; Li M; Tang Z; Li X; Song T
Br J Radiol; 2021 Sep; 94(1125):20201441. PubMed ID: 33882252
[TBL] [Abstract][Full Text] [Related]
2. Factors that Differentiate between Endometriosis-associated Ovarian Cancer and Benign Ovarian Endometriosis with Mural Nodules.
Tanase Y; Kawaguchi R; Takahama J; Kobayashi H
Magn Reson Med Sci; 2018 Jul; 17(3):231-237. PubMed ID: 28824051
[TBL] [Abstract][Full Text] [Related]
3. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
Erzen M; Rakar S; Klancnik B; Syrjänen K
Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary.
Morioka S; Kawaguchi R; Yamada Y; Iwai K; Yoshimoto C; Kobayashi H
J Ovarian Res; 2019 Feb; 12(1):20. PubMed ID: 30803452
[TBL] [Abstract][Full Text] [Related]
5. The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.
Ju UC; Kang WD; Kim SM
Int J Gynaecol Obstet; 2019 Aug; 146(2):177-183. PubMed ID: 31081117
[TBL] [Abstract][Full Text] [Related]
6. Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study.
Cai Y; Yin J; Jin Y; Li Y; Wu M; Yang J; Huang H; Leng J; Pan L
Eur J Surg Oncol; 2020 May; 46(5):876-882. PubMed ID: 31837932
[TBL] [Abstract][Full Text] [Related]
7. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics.
Li Q; Sun Y; Zhang X; Wang L; Wu W; Wu M; Meng C; Liu G
Cancer Biol Ther; 2019; 20(7):1029-1034. PubMed ID: 30913953
[No Abstract] [Full Text] [Related]
8. Clinical characteristics and serum CA19-9 combined with HE4 are valuable in diagnosing endometriosis-associated ovarian cancer.
Xu T; Zhang L; Jiang Y; Wan Y; Zhou S; Sun G; Cheng W; Yuan L
Int J Gynaecol Obstet; 2023 Aug; 162(2):472-478. PubMed ID: 36708088
[TBL] [Abstract][Full Text] [Related]
9. Does Endometriosis Hinder Successful Ovarian Debulking Surgery?
Sananpanichkul P; Muangtan S; Suknikhom W; Bhamarapravatana K; Suwannarurk K
Asian Pac J Cancer Prev; 2018 Feb; 19(2):509-512. PubMed ID: 29480993
[TBL] [Abstract][Full Text] [Related]
10. Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics.
Bassiouny D; El-Baz MA; Gamil TM; Shams N; Ismiil N; Dubé V; Han G; Cesari M; Lu FI; Slodkowska E; Chiu HF; Naeim M; Li N; Nofech-Mozes S; Khalifa MA
Int J Gynecol Pathol; 2019 Sep; 38(5):435-442. PubMed ID: 30059454
[TBL] [Abstract][Full Text] [Related]
11. The application of risk models based on machine learning to predict endometriosis-associated ovarian cancer in patients with endometriosis.
Chao X; Wang S; Lang J; Leng J; Fan Q
Acta Obstet Gynecol Scand; 2022 Dec; 101(12):1440-1449. PubMed ID: 36210724
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors of endometriosis associated ovarian carcinoma in women aged 45 years and older].
He ZX; Wang S; Li ZF; Zhu L; Leng JH; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):314-319. PubMed ID: 28545269
[No Abstract] [Full Text] [Related]
13. The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer.
Andersen CL; Boisen MM; Sikora MJ; Ma T; Tseng G; Suryawanshi S; Vlad A; Elishaev E; Edwards RP; Oesterreich S
Horm Cancer; 2018 Dec; 9(6):399-407. PubMed ID: 30302736
[TBL] [Abstract][Full Text] [Related]
14. Unexpected epithelial ovarian cancers arising from presumed endometrioma: A 10-year retrospective analysis.
Kuo HH; Huang CY; Ueng SH; Huang KG; Lee CL; Yen CF
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):55-61. PubMed ID: 28254227
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for endometriotic-cyst associated ovarian cancer: A case controlled study.
Udomsinkul P; Triratanachart S; Oranratanaphan S
Taiwan J Obstet Gynecol; 2020 Mar; 59(2):269-274. PubMed ID: 32127149
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of GLI1 and Shh in the malignant transformation of ovarian endometriosis].
Zhao F; Yu XP; Zhao H; Song BB; Lyu AW; Zhang SH; Wang LM
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):125-132. PubMed ID: 35184473
[No Abstract] [Full Text] [Related]
17. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.
Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions.
Bai H; Cao D; Yuan F; Sha G; Yang J; Chen J; Wang Y; Zhang Z; Shen K
Gynecol Oncol; 2016 Dec; 143(3):526-531. PubMed ID: 27745918
[TBL] [Abstract][Full Text] [Related]
20. A diagnostic challenge of seromucinous borderline tumor: A case report.
Liu T; Sumida D; Wada T; Maehana T; Yamawaki A; Sugimoto S; Kawahara N; Yoshimoto C; Kobayashi H
Medicine (Baltimore); 2019 May; 98(22):e15707. PubMed ID: 31145284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
